Zobrazeno 71 - 80
of 386
pro vyhledávání: '"Pierluigi Porcu"'
Autor:
Tingting Zhan, Megan O'Donnell, Pierluigi Porcu, Onder Alpdogan, Wenyin Shi, Saritha Kartan, Neda Nikbakht, Romsin Zaya, Doaa Shalabi
Publikováno v:
Journal of Dermatological Science. 98:98-101
Background Questionnaire tools are increasingly being used to assess health related quality of life (HRQOL) in mycosis fungoides (MF) patients. However, a thorough understanding of the factors that lead to poor HRQoL in early stage disease and their
Autor:
Pamela Heeter, Erika Cavallone, Frank McCormick, Lawrence K. Kaplan, Laura B. Pincus, Wade Berry, Basem M. William, Aaron Zhan, Khoan Vu, Jonathan E. Brammer, Chen-Yen Yang, Charalambos Andreadis, Matthew J. Wieduwilt, Pierluigi Porcu, Weiyun Z. Ai, Chi-Heng Wu
Publikováno v:
Clinical Cancer Research. 26:1000-1008
Purpose: The histone deacetylase (HDAC) inhibitor romidepsin and the anthracycline liposomal doxorubicin (LD) have modest single-agent activity in cutaneous T-cell lymphoma (CTCL) and peripheral T-cell lymphoma (PTCL). We investigated the safety and
Autor:
Michael Chang, Pierluigi Porcu, Li-Anne S Lim, Arman Mashayekhi, Lauren A Dalvin, Nina L. Martinez, Mehdi Mazloumi, Carol L. Shields, David Ancona-Lezama, Jon Glass
Publikováno v:
Asia-Pacific Journal of Ophthalmology. 9:110-116
Purpose The aim of this study was to identify clinical factors predictive of time to central nervous system (CNS) lymphoma or death in patients with vitreoretinal lymphoma (VRL). Design Retrospective cohort study. Methods Patients with VRL (n = 95 pa
Autor:
Chris Karlovich, Richard Shine, Jennifer H. Yearley, Martin A. Cheever, Pierluigi Porcu, Francine M. Foss, Steven M. Horwitz, Youn H. Kim, Alison J. Moskowitz, Michael S. Khodadoust, Wendy M. Blumenschein, P. Mickey Williams, Andrei R. Shustov, Vivekananda Datta, Erin Cantu, Biswajit Das, Lubomir Sokol, Yi Yang, Sophia Fong, Holden T. Maecker, Shufeng Li, Priyanka B. Subrahmanyam, Nirasha Ramchurren, Alain H. Rook, Elad Sharon, Satish Shanbhag, Jinah Kim, Robert H. Pierce, Steven P. Fling, Holbrook E Kohrt, Asa Davis, Justine N. McCutcheon, Rajesh Patidar
Publikováno v:
J Clin Oncol
PURPOSE To assess the efficacy of pembrolizumab in patients with advanced relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS). PATIENTS AND METHODS CITN-10 is a single-arm, multicenter phase II trial of 24 patients with advanced MF
Autor:
Kami J. Maddocks, Beth Christian, Amelia Langston, Mary Jo Lechowicz, Lai Wei, Steven M. Devine, Kristie A. Blum, Leonard T. Heffner, Christopher R. Flowers, Pierluigi Porcu, Jonathon B. Cohen
Publikováno v:
Cancer. 126:1235-1242
Background Both gemcitabine and bendamustine have been evaluated in patients with recurrent/refractory Hodgkin lymphoma but to the authors' knowledge not as a doublet. The authors completed a phase 1/2 trial to identify the optimal dose and frequency
Publikováno v:
Surgical Pathology Clinics. 12:783-803
This review describes the latest advances in the diagnosis of cutaneous T-cell lymphoma focusing on the most clinically useful features introduced since the publication of the World Health Organization revision in 2017. Clinical entities described in
Autor:
Mouneer Odeh, Dolores Grosso, Neal Flomenberg, Usama Gergis, Nicholas DeGregorio, Xia Bi, Dania Beadle, Thomas R. Klumpp, Christopher McNair, Joseph Neff, Pierluigi Porcu, Alexander Xu
Publikováno v:
JCO clinical cancer informatics. 5
PURPOSE An important obstacle to cancer research is that nearly all academic cancer centers maintain substantial collections of highly duplicative, poorly quality-assured, nonintercommunicating, difficult-to-access data repositories. It is inherently
Autor:
Yang Yang, Usama Gergis, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, William O'Hara, Adam Binder, Onder Alpdogan, Ubaldo Martinez-Outschoorn, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso
Publikováno v:
Transplantation and cellular therapy. 28(3)
The 2-step graft engineering approach has been the main platform for allogeneic hematopoietic cell transplantation (allo-HCT) at Thomas Jefferson University since 2005. We have previously described separating donor lymphocyte infusion followed by cyc
Autor:
Christopher R. Flowers, John M. Burke, Mirko Vukcevic, Susan Snodgrass, Kim Saverno, Mary Ann A. Lumiqued, Haifaa Abdulhaq, Elizabeth Brem, Andrew Evens, Umar Farooq, Pierluigi Porcu, Mazyar Shadman
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S171
Autor:
Julia Scarisbrick, Karen Dwyer, Martine Bagot, Pierluigi Porcu, Pier Luigi Zinzani, Youn H. Kim, Wei Sun, Steven M. Horwitz, Fiona Herr, Alison J. Moskowitz
Publikováno v:
Leukemialymphoma. 62(13)
Patients with mycosis fungoides (MF) and Sezary syndrome (SS) often require multiple lines of systemic therapy. In the phase 3 MAVORIC study (NCT01728805), mogamulizumab demonstrated superiority to vorinostat in median progression-free survival (PFS)